Clinical Trial

Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials

Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
Single-center phase II/III clinical investigation of the pharmacokinetics and pharmacodynamics of artemether-lumefantrine and dihydroartemisinin-piperaquine for gametocyte clearance and post-treatment chemoprotection in Zambian children with uncomplicated falciparum malaria.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2019-07-03; most recent amendment 2025-12-09.
Status change: Recruiting → Active, Not Recruiting 2020-08-07
Trial Details
NCT Number NCT04009343
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: Tropical Diseases Research Centre
Conditions Uncomplicated Falciparum Malaria
Enrollment 182 participants
Start Date 2019-06-19
Primary Completion 2020-08-24 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-17